Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary.
Biological Nanochemistry Research Group, Research Centre for Natural Sciences, Budapest, Hungary.
Front Immunol. 2019 Dec 20;10:2967. doi: 10.3389/fimmu.2019.02967. eCollection 2019.
causes localized infections or invasive diseases (abscesses or endocarditis). One of its virulence factors is staphylocoagulase (SCG), which binds prothrombin to form a complex with thrombin-like proteolytic activity and leads to uncontrolled fibrin generation at sites of bacterial inoculation. The aim of this study was to characterize the formation, structure, mechanical properties and lysis of SCG-generated clots. Recombinant SCG was expressed in , purified and the amidolytic activity of its complexes with human prothrombin (SCG-PT) and thrombin (SCG-T) was determined using human thrombin as a reference. Fibrin clots were prepared from purified fibrinogen and human plasma using thrombin, SCG-PT or SCG-T as a coagulase. The kinetics of clot formation and lysis by tissue-type plasminogen activator (tPA) were monitored with turbidimetric assays. Fibrin ultrastructure was examined with scanning electron microscopy and small-angle X-ray scattering (SAXS). Fibrin clot porosity was characterized with fluid permeation assays, whereas the viscoelastic properties and mechanical stability were evaluated with oscillation rheometry. Compared to thrombin, the amidolytic and clotting activity of SCG-PT was 1.6- to 2.5-fold lower on a molar basis. SCG-T had equivalent amidolytic, but reduced clotting activity both on pure fibrinogen (1.6-fold), and in plasma (1.3-fold). The SCG-PT and SCG-T generated fibrin with thicker fibers (10-60% increase in median diameter) than thrombin due to increased number of fibrin protofibrils per fiber cross-section. According to the fluid permeability of the clots SCG-PT and SCG-T promoted the formation of more porous structures. The shear stress resistance in the pure fibrin and plasma clots generated by SCG-PT was significantly lower than in the thrombin clots (243.8 ± 22.0 Pa shear stress was sufficient for disassembly of SCG-PT fibrin vs. 937.3 ± 65.6 Pa in thrombin clots). The tPA-mediated lysis of both pure fibrin and plasma clots produced by SCG-PT or SCG-T was accelerated compared to thrombin, resulting in up to a 2.1-fold increase in tPA potency. Our results indicate that SCG generates a thrombus scaffold with a structure characterized by impaired mechanical stability and increased lytic susceptibility. This proneness to clot disintegration could have implications in the septic embolism from endocardial bacterial vegetation.
金黄色葡萄球菌凝固酶(staphylocoagulase,SCG)可导致局部感染或侵袭性疾病(脓肿或心内膜炎)。其毒力因子之一是葡萄球菌凝固酶(staphylocoagulase,SCG),它可将凝血酶原与血栓酶结合形成具有类似凝血酶的蛋白水解活性的复合物,导致在细菌接种部位失控地产生纤维蛋白。本研究旨在描述 SCG 生成的血栓的形成、结构、力学性能和溶解特性。通过表达、纯化重组 SCG,并以人凝血酶为参比,测定其与人凝血酶原(SCG-PT)和凝血酶(SCG-T)复合物的 amidolytic 活性。使用纯化的纤维蛋白原和人血浆,用凝血酶、SCG-PT 或 SCG-T 作为凝固酶制备纤维蛋白凝块。通过比浊法监测组织型纤溶酶原激活物(tPA)引起的凝块形成和溶解的动力学。使用扫描电子显微镜和小角 X 射线散射(SAXS)检查纤维蛋白超微结构。使用流体渗透测定法表征纤维蛋白凝块的孔隙率,通过振荡流变测量评估粘弹性和机械稳定性。与凝血酶相比,SCG-PT 的 amidolytic 和凝血活性在摩尔基础上低 1.6-2.5 倍。SCG-T 具有等效的 amidolytic,但在纯纤维蛋白原(1.6 倍)和血浆(1.3 倍)中的凝血活性降低。由于纤维蛋白原原纤维的数量增加,SCG-PT 和 SCG-T 生成的纤维蛋白纤维较厚(纤维直径中位数增加 10-60%)。根据凝块的流体渗透性,SCG-PT 和 SCG-T 促进了更多孔结构的形成。与凝血酶相比,SCG-PT 在纯纤维蛋白和血浆凝块中的剪切应力阻力明显降低(足以使 SCG-PT 纤维蛋白解聚的剪切应力为 243.8 ± 22.0 Pa,而凝血酶凝块为 937.3 ± 65.6 Pa)。与凝血酶相比,SCG-PT 或 SCG-T 生成的纯纤维蛋白和血浆凝块的 tPA 介导的溶解均被加速,导致 tPA 效力增加高达 2.1 倍。我们的结果表明,SCG 生成的血栓支架结构特征为机械稳定性降低和溶解易感性增加。这种倾向于血栓崩解可能与心内膜细菌植被的败血症栓塞有关。